Recurrent urinary tract infections and bladder dysfunction in systemic lupus erythematosus

Abstract

To assess bladder function in systemic lupus erythematosus (SLE) patients with recurrent urinary tract infections (UTIs). A convenience sample of consecutive patients with SLE (American College of Rheumatology criteria), with recurrent UTIs (≥3 events in the preceding 12 months), without history of central nervous system involvement, urolithiasis or preceding tuberculosis were studied. Disease activity (SLEDAI-2K), damage (SDI), lower urinary tract symptoms [Pelvic pain and Urgency/Frequency (PUF) and the Interstitial Cystitis Symptom and Problem Index (ICSPI) scales] and Autonomic Symptom Profile (ASP) were assessed. All patients underwent urological examination and urodynamic assessment with cystometry, uroflow, micturition and urethral pressure profile. Ten patients (nine women) were included. The majority of the patients reported urinary symptoms: urgency (n = 8), frequency (n = 8), nocturia (n = 9) and pain (n = 10). The patients had a mean (SD) ICSPI score of 18.4 (9.8), PUF score of 17.4 (5.3) and ASP weighted score of 31.7 (16.1). Abnormal urodynamics findings were identified in seven of the 10 patients, including small bladder capacity (two patients), reduced bladder sensation (four patients), subnormal urinary flow rate (one patient) and a significant amount of residual urine (two patients). The urodynamics findings suggest that bladder dysfunction could be one of the mechanisms involved on the occurrence of recurrent UTIs in patients with SLE. These findings have potential implications for the proper assessment and management of SLE patients with recurrent UTIs. Further studies are needed to corroborate our results.

Keywords

bladder dysfunction systemic lupus erythematosus urinary tract infections urodynamics

Get full access to this article

View all access options for this article.

References

1 Duffy KN Duffy CM Gladman DD . Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients. J Rheumatol 1991; 18: 1180–1184.

2 Hidalgo-Tenorio C Jimenez-Alonso J de Dios LJ . Urinary tract infections and lupus erythematosus. Ann Rheum Dis 2004; 63: 431–437.

3 Haarala M Alanen A Hietarinta M Kiilholma P . Lower urinary tract symptoms in patients with Sjogren's syndrome and systemic lupus erythematosus. Int Urogynecol J Pelvic Floor Dysfunct 2000; 11: 84–86.

4 Yu HJ Lee WC Lee KL Chen MY Chen CY Chen J . Voiding dysfunction in women with systemic lupus erythematosus. Arthritis Rheum 2004; 50: 166–172.

5 Weisman MH McDanald EC Wilson CB . Studies of the pathogenesis of interstitial cystitis, obstructive uropathy, and intestinal malabsorption in a patient with systemic lupus erythematosus. Am J Med 1981; 70: 875–881.

6 Boye E Morse M Huttner I Erlanger BF Mackinnom KJ Klassen J . Immune complex-mediated interstitial cystitis as a major manifestation of systemic lupus erythematosus. Clin Immunol Immunopathol 1979; 13: 67–76.

7 Orth RW Weisman MH Cohen AH Talner LB Nachtsheim D Zvaifler NJ . Lupus cystitis: primary bladder manifestations of systemic lupus erythematosus. Ann Intern Med 1983; 98: 323–326.

8 Koike T Takabayashi K . Lupus cystitis in the Japanese. Intern Med 1996; 35: 87–88.

9 Alarcon-Segovia D Abud-Mendoza C Reyes-Gutierrez E Iglesias-Gamarra A Diaz-Jouanen E . Involvement of the urinary bladder in systemic lupus erythematosus. A pathologic study. J Rheumatol 1984; 11: 208–210.

10.

10 Hochberg MC . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.

11.

11 Gladman DD Ibanez D Urowitz MB . Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29: 288–291.

12.

12 Gladman DD Goldsmith CH Urowitz MB . The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 2000; 27: 373–376.

13.

13 Parsons CL Dell J Stanford EJ . Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology 2002; 60: 573–578.

14.

14 O’Leary MP Sant GR Fowler FJ Whitmore KE Spolarich-Kroll J . The interstitial cystitis symptom index and problem index. Urology 1997; 49: 58–63.

15.

15 Suarez GA Opfer-Gehrking TL Offord KP Atkinson EJ O’Brien PC Low PA . The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. Neurology 1999; 52: 523–528.

16.

16 Schafer W Abrams P Liao L . Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 2002; 21: 261–274.

17.

17 Abrams P Cardozo L Fall M . The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167–178.

18.

18 Kohli N Karram MM . Urodynamic evaluation for female urinary incontinence. Clin Obstet Gynecol 1998; 41: 672–690.

19.

19 Bosch X Guilabert A Pallares L . Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus 2006; 15: 584–589.

20.

20 Kang I Park SH . Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol 2003; 15: 528–534.

21.

21 Wullt B Bergsten G Fischer H . The host response to urinary tract infection. Infect Dis Clin North Am 2003; 17: 279–301.

22.

22 Leppilahti M Tammela TL Huhtala H Kiilholma P Leppilahti K Auvinen A . Interstitial cystitis-like urinary symptoms among patients with Sjogren’s syndrome: a population-based study in Finland. Am J Med 2003; 115: 62–65.

23.

23 Waterman SA Gordon TP Rischmueller M . Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren’s syndrome. Arthritis Rheum 2000; 43: 1647–1654.

24.

24 D’Cruz DP Khamashta MA Hughes GR . Systemic lupus erythematosus. Lancet 2007; 369: 587–596.

25.

25 Levine LA Richie JP . Urological complications of cyclophosphamide. J Urol 1989; 141: 1063–1069.

26.

26 Maule S Quadri R Mirante D . Autonomic nervous dysfunction in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA): possible pathogenic role of autoantibodies to autonomic nervous structures. Clin Exp Immunol 1997; 110: 423–427.

27.

27 Shalimar, Handa, R, Deepak, KK, Bhatia, M, Aggarwal, P, Pandey, RM. Autonomic dysfunction in systemic lupus erythematosus. Rheumatol Int 2006; 26: 837–840.

28.

28 Stojanovich L Milovanovich B . de Luka, Sr, et al. Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjogren syndrome and other autoimmune diseases. Lupus 2007; 16: 181–185.

29.

29 Wada T Yokoyama H Ikeda K Tomosugi N Kobayashi K . Neurogenic bladder due to peripheral neuropathy and a visual disturbance in an elderly man with systemic lupus erythematosus. Ann Rheum Dis 1992; 51: 547–549.

30.

30 Hoyle C Ewing DJ Parker AC . Acute autonomic neuropathy in association with systemic lupus erythematosus. Ann Rheum Dis 1985; 44: 420–424.

31.

31 Gamez-Nava JI Gonzalez-Lopez L Ramos-Remus C Fonseca-Gomez MM Cardona-Muñoz EG Suarez-Almazor ME . Autonomic dysfunction in patients with systemic lupus erythematosus. J Rheumatol 1998; 25: 1092–1096.

32.

32 Gillenwater JY; Wein AJ; . Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28–29, 1987. J Urol 1988; 140: 203–206.